Adverse events and laboratory abnormalities were monitored over 35 days after the commencement of treatment in 45 open studies conducted in Europe, South America, Africa and Asia. These studies were to assess the clinical efficacies of azithromycin and comparator antimicrobial agents in the treatment of paediatric acute bacterial infections.
This study was designed to evaluate the efficacy of a 3 day course of azithromycin in low to moderately severe community-acquired pneumonia
Although universal immuni-zation against Bordetella pertussis(whooping cough) infection has resulted in dramatic reductions in the incidence of pertussis, outbreaks continue to occur in countries with excellent vaccine coverage.
Despite increasing concerns over macrolide resistance and a higher incidence of Gram-negative pathogens, a standard 5-day course of oral azithromycin was clinically and bacteriologically equivalent to a 7-day course of oral levofloxacin in the treatment of patients with ABECB.
Dexan, pernahkah merasakan penglihatan mulai menurun atau berubah? Pneglihatan yang awalnya jernih menjadi berkabut? Atau, penglihatan malam Dexan menjadi berkurang? Pernah atau tidak, ini adalah kesempatan emas untuk Dexan mempelajari tentang kesehatan mata, gejala penyakit mata penyebabnya, pengobatannya hingga pencegahan yang bisa Dexan lakukan
Anda adalah pribadi yang Amazing dan itu tidak dapat dibantah. Walaupun mungkin Anda sendiri tidak menyadarinya. Diri Anda yang sekarang adalah hasil dari serangkaian persitiwa yang telah Anda lewati dan melalui proses panjang. Anda, sang pemeran utama dalam hidup sedang berjuang memberikan pertunjukan yang menakjubkan. Apa yang Anda perjuangkan saat ini menentukan akhir dari cerita hidup Anda.…
This study aimed to investigate the immunomodulatory activation of low-molecular-weight peptides from monkfish (Lophius litulon) roe (named MRP) on cyclophosphamide (CTX)-induced immunosuppressed mice. Our results indicated that MRP (100 mg/kg/d BW) could significantly increase the body weight and immune organ index, and improve the morphological changes in the spleen and thymus of mice. These …
To review key trials of monotherapy and combination therapy of a1-adrenergic receptor antagonists (a1-ARAs), 5a-reductase inhibitors (5aRIs) and anti-muscarinic agents in the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). To assess the safety and efficacy of combination therapies for LUTS associated with BPH, a search of the MEDLINE and Coch…